92
Views
3
CrossRef citations to date
0
Altmetric
Review Article

Reducing the average number of patients needed in a phase II trial through novel design

Pages 47-54 | Received 19 Sep 2013, Accepted 09 Oct 2013, Published online: 04 Nov 2013
 

Abstract

Phase II represents a very important part of the drug development process. It is important that genuinely effective treatments have a high chance of succeeding whilst treatments that will fail at phase III are screened out. Because of the high number of treatments available for testing and limited resources and patients available, it is increasingly of interest to apply novel designs to improve the efficiency of phase II trials. This paper shall argue that phase II presents the most promising area for applying novel designs and will review some recent developments in three classes of novel design: group-sequential designs, multi-arm designs, and enrichment designs. All three types of design considerably improve the efficiency of phase II trials on average and also ensure that patients are more likely to be treated with the best available treatment for them. Although the designs have drawbacks, the considerable advantages mean that these designs will become increasingly important in phase II.

Acknowledgements

This work was funded by the UK Medical Research Council (grant numbers G0800860 and MR/J004979/1). I would like to thank Emma McCallum and two anonymous reviewers for comments on this manuscript.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access
  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart
* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.